Pasquale Caponnetto, CoEHAR member, unveiled two brand new research project during the XXX Congress of the Italian Association of Psychology, Genesis and Ceasefire. Two projects concerning mental health, smoking addiction and combustion-free products
The Replica project team activity and the results of the studies on the reduced cytotoxicity and inflammation induced by cigarette smoke and ENDS aerosol will be presented during the XVI edition of the Congress of the Italian Federation of Life Sciences (FISV), which represents over 10.0000 Italian scientists and which will take place from 14 to 16 September 2022 in Naples
The mapping of Global Research on electronic cigarettes showed that prof. Riccardo Polosa (CoEHAR Center of Excellence for the Acceleration of HArm Reduction, University of Catania) and prof. Maciej L. Goniewicz (Roswell Park Comprehensive Cancer Center, USA) are the most influential authors and the most important researchers in the e-cigarettes research field.
The prestigious American Journal of Respiratory and Critical Care Medicine published a comment by researchers from CoEHAR and the University of Messina regarding a US studies that concluded that “former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms”. According to the Italian authors “the significance of the findings needs careful review”.
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.
A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
Yesterday, the Italian Ministry of Health released new data on smoking prevalence: there are 800000 more smokers in the country than in 2019. Rates increased especially among women and young people. The report found that also the numbers of the users of heated tobacco products and electronic cigarettes is rising. “An expected disaster, partly anticipated by our data published in 2020 and obtained thanks to a study conducted during the acute phase of Covid-19 pandemic. Since then, no prevention policies, no answers from the Italian health authorities. Reporting a disaster is not enough: we need to come up with alternative and effective solutions”. Stated professor Riccardo Polosa, founder of the CoEHAR, who opened the first National Conference on Tobacco Harm Reduction.
On 31 May 2022, to celebrate the World No Tobacco Day, CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, will host the first National Conference on Tobacco Harm Reduction “Risks and benefits of Combustion free products".
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.